Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02952352 · ClinicalTrials.gov registry record · NA
Nxstan: A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
NCT02952352: Completed NA study, sponsored by Washington State University.
NCT02952352 is a NA study that has completed, run by Washington State University. The registered enrollment target is 113 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02952352, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
Study Summary
To reduce modifiable diabetes risk factors' in overweight and obese AI men residing on the Colville reservation through a community-based, culturally informed intervention, the study specifically aims to: 1. conduct focus groups and interviews with adult members of Colville tribe to inform the adaptation, manualization and implementation of a culturally informed diabetes prevention program among overweight and obese AI men; 2. evaluate the effectiveness of a community-based, culturally informed diabetes prevention intervention by assessing between group changes.
Primary Outcome
Percent weight loss
Interventions
- BEHAVIORAL Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2019-03-30 |
| Phase | NA |
What the finished NCT02952352 record still lists
NCT02952352 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Diabetes Prevention Program is the first listed.
NCT02952352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02952352 about?
NCT02952352 is a clinical study titled "Nxstan: A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men". To reduce modifiable diabetes risk factors' in overweight and obese AI men residing on the Colville reservation through a community-based, culturally informed intervention, the study specifically aims to: 1. conduct focus groups and interviews with adult members of Colville tribe to inform the adapt...
What is the current status of trial NCT02952352?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2017-03-01. Estimated completion is 2019-03-30.
What interventions are being tested in trial NCT02952352?
The interventions under investigation include: Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02952352?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02952352's enrollment target sits among peer trials
113 813th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI